BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 4, 2016
View Archived Issues
Avalanche Biotechnologies to acquire Annapurna Therapeutics
Read More
Starpharma reports additional preclinical results for targeted dendrimer conjugate
Read More
FDA grants fast track designation to NDI-010976 for NASH
Read More
Oricula Therapeutics receives NIH grant to support development of ORC-13661
Read More
Mersana and Takeda expand partnership to advance development of Fleximer-based ADC therapies
Read More
Bayer Schering Pharma patents GLUT-1 inhibitors
Read More
Roche discloses BACE1 inhibitors
Read More
Merck & Co. develops ROMK channel blockers
Read More
Shionogi reports ITK inhibitors
Read More
FDA grants fast track designation for emricasan as treatment of patients with NASH cirrhosis
Read More
Shareholders approve Pozen merger with Tribute Pharmaceuticals
Read More
New AAV variant transfers genes throughout the CNS in vivo
Read More
Modulate Therapeutics established to develop immunomodulator combination IMM-01
Read More
Greenville Health System and Selah Genomics launch test for risk of sudden cardiac death
Read More
Heat Biologics provides update on its HS-410 phase II bladder cancer trial
Read More
Takeda Pharmaceutical to create wholly owned consumer healthcare subsidiary
Read More
Human fallopian tube organoid model faithfully recapitulates the mucosal fold architecture
Read More
Kyorin returns Japanese rights to aclidinium/formoterol to AstraZeneca
Read More
Defibrotide deemed effective against veno-oclussive disease in phase III trial
Read More
Pfizer profiles pipeline progress of fourth quarter 2015
Read More
Exosome-encapsulated paclitaxel shows promise to treat drug-resistant cancers
Read More
FDA grants fast track designation to TapImmune's TPIV-200 for ovarian cancer
Read More
FDA advisory committee votes on Brintellix to treat cognitive dysfunction in MDD
Read More
Mitsubishi Tanabe Pharma updates progress of third quarter of fiscal 2015
Read More
Morphotek provides folate receptor alpha diagnostic assays for Mayo Clinic study
Read More
GeoVax Labs announces its plans to develop Zika virus vaccine
Read More
Fast Forward Pharmaceuticals begins phase II studies of FFP-104
Read More